Indication
Cardiovascular Events
3 clinical trials
6 products
Clinical trial
Effect of Evolocumab on Chronic Total Occlusions After Successful Percutaneous Coronary Intervention (EVOLO-CTO)Status: Recruiting, Estimated PCD: 2024-12-01
Product
PCSK9 inhibitorProduct
StatinClinical trial
PCSK 9 Inhibitor Added to High-Intensity Statin Therapy to Prevent Cardiovascular Events in Patients With Acute Coronary Syndrome After Percutaneous Coronary Intervention: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter StudyStatus: Recruiting, Estimated PCD: 2026-01-30
Product
PCSK 9 InhibitorClinical trial
Relative Vaccine Effectiveness of Adjuvanted Quadrivalent Inactivated Influenza Vaccine vs High-Dose Quadrivalent Inactivated Influenza Vaccine Among Adults ≥65 Years for the 2023-24 and 2024-25 SeasonsStatus: Recruiting, Estimated PCD: 2025-05-01